GR
Gunasekaran Rajakumar
About Gunasekaran Rajakumar
Data last updated:
Gunasekaran Rajakumar is a Managing Director at Medlogix Pharma Private Limited (since 2024) and Managing Director at Genremedy Pharmaceuticals Private Limited (since 2024). The companies operate in Pharma and Chemicals. The largest current company by reported revenue is Medlogix Pharma Private Limited at ₹2.58 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medlogix Pharma Private Limited U74999TN2018PTC124792 | Managing Director | 12 Dec 2024 | 2018 | ₹2.58 Cr (FY 2024) | Active |
 Genremedy Pharmaceuticals Private Limited U24239TN2019PTC150059 | Managing Director | 12 Dec 2024 | 2019 | Active |
Board colleagues of Gunasekaran Rajakumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Krishnamoorthi Madhanagopal | 08234221 | Medlogix Pharma Private Limited | Director |
| Munusamysah Srinivasan | 08672243 | Medlogix Pharma Private Limited , Genremedy Pharmaceuticals Private Limited | Director |
| Veeraiyan Karthikeyan | 08481186 | Genremedy Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gunasekaran Rajakumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gunasekaran Rajakumar
Gunasekaran Rajakumar currently holds 2 directorships: Medlogix Pharma Private Limited (Managing Director, since 12 Dec 2024, revenue ₹2.58 Cr (FY 2024)); Genremedy Pharmaceuticals Private Limited (Managing Director, since 12 Dec 2024).
Gunasekaran Rajakumar was first appointed on 12 Dec 2024 as Managing Director at Medlogix Pharma Private Limited.
The current boards of Gunasekaran Rajakumar's companies include Krishnamoorthi Madhanagopal (Medlogix Pharma Private Limited), Munusamysah Srinivasan (Medlogix Pharma Private Limited), Veeraiyan Karthikeyan (Genremedy Pharmaceuticals Private Limited).